Close Menu

NEW YORK (GenomeWeb) – SpeeDx, an Australia-based manufacturer of diagnostic test kits, announced today that it has expanded its footprint in the Middle East through a new distribution partnership.

The partnership with Al Zahrawi Medical Supplies will enable distribution of the firm's SpeeDx Resistance Plus and PlexPCR portfolios in the United Arab Emirates, Saudi Arabia, Bahrain, Qatar, and Oman.

The SpeeDx ResistancePlus tests combine infection detection with detection of genetic markers of antibiotic resistance.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

According to NPR, an antibody-based test could identify people who were exposed to SARS-CoV-2 and either didn't develop symptoms or were misdiagnosed.

A sequencing analysis of New York City rats indicates they have adapted to the urban environment there, according to a recent preprint.

Ars Technica reports that a multicellular eukaryotic parasite has lost its mitochondria.

In Science this week: perspective piece says AI can accelerate drug discovery by using genomic and chemical data, and more.

Mar
18
Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.